PharmaForce 2017

September 18 - 20, 2017

Hilton Austin, TX

Contact Us: 1.888.482.6012

Speakers

Robert Lisicki
 Robert Lisicki 
SVP, Chief Customer Officer 
Daiichi Sankyo
Rob has successfully led US, International and Global commercial teams over the course of his career. 
Currently, he serves as the Senior Vice President & Chief Customer Officer at Daiichi-Sankyo, having joined in August 2014. Rob is accountable for leading the transformation of Daiichi-Sanyko from a large Primacy Care Company to a Specialty Company with a focus on Oncology, Pain and Rare Disease. 

Prior to joining Daiichi Sankyo, Rob was Vice President of Sales for the Amgen Bone & Cardiology division, where he helped drive Prolia to blockbuster status and contributed to the build and development of the Amgen cardiovascular commercial structure. Prior to leading sales, Rob served as the Executive Director of Marketing for Amgen's flagship products Enbrel, Aranesp and Prolia. He spent two years as a Therapeutic Area lead of Nephrology and CV in Zug, Switzerland, where he had global P&L responsibility for the Nephrology and Cardiology non-US franchise. He also held responsibility for International Commercial Operations, Sales Force Effectiveness for all non-US Oncology and Bone business and developed innovative approaches to mining key insights from customer to drive uptake of in-line products.

Before his tenure at Amgen, Rob spent 13 years at Johnson & Johnson Corporation where he experienced career progression in several roles spanning product management, sales and sales management and won the prestigious Telly Award for excellence in advertising and marketing. Rob has launched and worked on several blockbuster products over his 20 year career in pharma and biotechnology. 
 
Rob holds a Bachelor of Science in Finance and Business Administration and Psychology  from the State University of New York at Albany, and has completed executive training at the Johnson & Johnson School of Advertising I and II and at the Wharton School of the University of Pennsylvania. . He is a past winner of the prestigious Telly Award for excellence in advertising and marketing.  Rob is a published author of “What Matters to Patients and Physicians When Considering Biologic Therapy for Rheumatoid Arthritis.” 

Kent Rogers
 Kent Rogers 
SVP, Industry Relations, OptumRX 
UnitedHealth Group
Kent currently serves as the Senior Vice President, Industry Relations for OptumRx with responsibility for formulary and procurement contracting for all books of business on behalf of internal and external clients of United Health Group. OptumRx is the pharmacy benefit management division of Optum servicing over 66 million members and processing over 1 billion pharmacy claims which represent over $80 billion in drug spend.

He has more than 25 years of experience with the pharmaceutical industry, focusing primarily on payer, channel and patient services strategies. Prior to OptumRx, Kent was a Principal Consultant with Blue Fin Group, served as the Vice President of Managed Markets at Acorda Therapeutics, and held various positions of increasing responsibility within Sales and Managed Markets at Schering Plough and Merck. His career experience includes business development, health economics/outcomes research, building and leading market access teams, developing and implementing payer access and channel strategies, and launching patient services programs.

Kent has a Bachelor of Science in Business Management from Indiana University, and an MBA from Emory University’s Goizueta School of Business.  

Bharti Rai
 Bharti Rai 
Chief Commercial Data Officer 
Bayer
Jon Zwinski
 Jon Zwinski 
Senior Vice President, Sales 
Chiesi USA Inc
Jay Graves
 Jay Graves 
VP, Sales 
Roche
Adam Houston
 Adam Houston 
Associate Director, Cross Brands Marketing 
Takeda Pharmaceuticals USA, Inc.
Debra Hussein
 Debra Hussein 
Head of Marketing 
Lilly USA, LLC
John Alter
 John Alter 
VP, Patient & Health Impact, Pfizer Essential Health Business Unit 
Pfizer
John is currently Vice President, Global Health and Value for Pfizer’s Essential Health business unit, which has worldwide sales of more than $20B from a portfolio of over 700 molecules including biosimilars, sterile injectables and solid oral dosage forms. The portfolio is the result of Pfizer’s research and development as well as from the acquisitions of Warner Lambert, Pharmacia and Upjohn, Wyeth and most recently Hospira. Pfizer is the world’s leading biosimilars company based on audited sales and its portfolio of biosimilar molecules is for the treatment of inflammation, oncology and supportive care.

Pfizer’s Global Health and Value team covers the functions of Pricing, Access, Reimbursement, Health Economics, Outcomes Research and Real World Data.  John has been with Pfizer for over 18 years in multiple roles of increasing responsibilities, the last three years in his current role.  He has presented at several biosimilars conferences on the topic of pricing and access and in 2016 was a guest lecturer on the subject of HEOR at Kings College London as part of the International Federation of Association of Pharmaceutical Physicians.

Tom Mccourt
 Tom Mccourt 
CCO, SVP, Marketing & Sales 
Ironwood Pharmaceuticals
Jonathan Barrett
 Jonathan Barrett 
Vice President, Oncology Marketing, US. 
EMDSerono
Mike Moran
 Mike Moran 
VP, Sales 
Eagle Pharmaceuticals
David Fortanbary
 David Fortanbary 
Head Of Commercial Training 
UCB Pharmaceuticals
David Lewis
 David Lewis 
VP Marketing 
Valeritas
Riad Dirani
 Riad Dirani 
VP, Global HEOR 
Teva Pharmaceuticals
Riad Dirani, PhD, is currently the VP of Global Health Economic and Outcomes Research at Teva Pharmaceuticals. His responsibilities include overseeing the establishment of this function within Medical Affairs, and developing the strategic capabilities for HEOR to optimize the development and commercialization of Teva’s portfolio of products and offerings globally.

Riad has worked in the pharmaceutical industry since 2000, including positions of increasing responsibility at Aventis, GlaxoSmithKline, Pfizer, and Johnson & Johnson in multiple therapeutic areas. Riad joined Teva in 2014 to build the HEOR group and establish it operating model. 

Riad received his Ph.D. in Health Services Research/Health Economics from The Pennsylvania State University. He has published over 25 journal articles and made numerous presentations to professional organizations, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and therapeutic-specific conferences. 

Aleks Alacahan
 Aleks Alacahan 
VP, Sales 
Salix Pharmaceuticals. Ltd.
Aleks Alacahan serves as Vice President, US Sales for GI, Key Accounts and Pain divisions of Salix Pharmaceuticals, bringing nearly 20 years of commercial experience within the biopharmaceutical industry.  He was promoted to Vice President in December 2015 after serving as Director of Sales for US-West since January, 2014. Mr. Alacahan joined Salix in 2009, during a pivotal time, helping springboard Salix to being the class-leading GI organization it is today.  He played a critical role in the introduction of portfolio-expansion products, including the successful launch of Xifaxan (a non-systemic antibiotic) for hepatic encephalopathy and irritable bowel syndrome (IBS-D).  Mr. Alacahan was instrumental in the building, development, and management of several specialized sales teams across multiple channels. Prior to Salix, he spent 8 years at DEY Pharmaceuticals, holding various leadership positions in Allergy, Asthma and COPD in the US Market.  Mr. Alacahan earned his Bachelor of Science degree in Business Management from Fairleigh Dickinson University in Madison, NJ and is pursuing his MBA at COX School of Business in Dallas, TX.  He is also a member of several distinguished healthcare organizations, striving to advance solutions in the healthcare sector.
Kasia Hein-Peters
 Kasia Hein-Peters 
Head of Vaxelis (PR5I) and Marketing 
Sanofi
Jennifer Muszik
 Jennifer Muszik 
Commercial Excellence Director 
Roche Diagnostics Corporation
Jim Lefevere
 Jim Lefevere 
Director, Marketing Strategy & Services 
Roche
Jim Lefevere is an award-winning marketing leader and innovative global marketing and commercial operations professional in consumer goods, health care, and medical devices. He combines senior marketing experience with a pioneering entrepreneurial vision. Named one of the Top Forty business professionals under 40 by the Indianapolis Business Journal, He has lead marketing efforts for Fortune 100 organizations, industry consortium and fast growth start-ups. A respected expert on digital marketing and health care, he has been called a Social Media Pioneer and a Digital Health Scholar. His focus is on creating marketing and digital strategies that connect, engage and make a difference. He currently heads global marketing strategy and services along with digital marketing for a division of the world’s largest bio-tech company and a leader in research driven health care.
Brian Peters
 Brian Peters 
Vice President, Marketing 
Medac Pharma
John O'Connor
 John O'Connor 
VP, Sales 
AMAG Pharmaceuticals
Michael Lombard
 Michael Lombard 
Hospital CEO 
Cornerstone Health
Michael Capaldi
 Michael Capaldi 
Lead, US Public Affairs Cardiovascular Unit 
Sanofi
Keith Willis
 Keith Willis 
Associate Director, Cardiovascular, Sales Training 
Bristol Myers Squibb
Jennifer Adams
 Jennifer Adams 
Director, Global Marketing 
Bristol-Myers Squibb Company
Jennifer Adams is the Worldwide Marketing Operations Lead at Bristol Myers Squibb. She has been instrumental in setting up the Marketing Operations role and model in the US and its expansion across EU/EMAC and Asia.  She will be speaking at PharmaForce on the transformation of the Worldwide BMS Marketing execution model, efficiencies gained through transformation and her recent rollout of the new work management software, Workfront.
In addition to her most recent achievments, Jennie spent over 17 years in Financial Services, launching her career supervising a call center in Global Operations, moving to Strategies in Capital Markets where Jennie pioneered a digital solution in lieu of a paper/fax process for 250,000 financial advisors. She spent 9 of those years building out a long-lasting, third party strategy and multi-channel benefit portal for millions of users within Interactive Marketing, still in use today.
While she does have a loyal track record for sustained employment at large public companies such as Prudential Securities, Citigroup and BMS; Jennie did spend some time in the Non-Profit sector as well, reengineering a web site platform and implementing a complex CMS.  She also ran the Digital in-house agency at BMS, streamlining communications and improving relationships globally.
Jennie has won a W3 award for her Non-Profit site, multiple BMS Spot and Bravo awards and the Trailblazer award in 2013, and either led or managed all three Cooperation Awards.  She has a BS from Arizona State University in Sociology and completed a Wharton Executive course, Advancing Business Acumen in 2014.

Neil Keene
 Neil Keene 
Former Senior Associate Director, Customer Engagement Strategy 
Boehringer Ingelheim
Brad Hummel
 Brad Hummel 
Oncology Sales Training Consultant 
Bristol-Myers Squibb
Igor Rudychev
 Igor Rudychev 
Commercial Analytics Director 
Pfizer
Jason Morhart
 Jason Morhart 
Associate Director, Urology Marketing 
Astellas
Jason Morhart is the Urology Marketing Director at Astellas Pharma Inc. leading the healthcare professional channel marketing efforts.  He has over 18 years of pharmaceutical industry experience, including various roles in sales and marketing at Bristol-Myers Squibb, Hospira, and Accera Inc., before joining Astellas in 2012.  His experience in Dermatology, Neuroscience, HIV/AIDS, Critical Care, Oncology and Urology is in a variety of traditional pharma and start-up environments.  He also serves as a Lieutenant Colonel in the United States Army Reserve with over 23 years combined active and reserve duty.  Jason received his Bachelor of Arts degree in Biology from University of Colorado, Boulder and Master of Business Administration degree from Notre Dame.

Najur Runganadhan
 Najur Runganadhan 
Strategic Insights & Analytics 
Novartis
Ben Locwin
 Ben Locwin 
Global Head of Research and Development Learning 
Biogen
Matt Barry
 Matt Barry 
Associate Director, Urology Marketing 
Astellas
Lawrence Bressler
 Lawrence Bressler 
Senior Director, US Launch Lead- Rare Disease 
Shire
Mark Pizzini
 Mark Pizzini 
Internal Medicine Business Technology Lead 
Pfizer
Adam Shandler
 Adam Shandler 
Talent Acquisition and Talent Development Associate Director 
Dr. Reddys
Jason Menzo
 Jason Menzo 
Sales and Marketing Vice President 
Sun Pharmaceuticals
Jill Donahue
 Jill Donahue 
Author 
EngageRX
Amy Tamburrino
 Amy Tamburrino 
Assoc.Director, Sales Force Effectiveness 
Lundbeck, Inc
Tracy Yedlin
 Tracy Yedlin 
Sr. Manager, Customer Engagement and Innovation 
Takeda Pharmaceuticals
Dallas Moores
 Dallas Moores 
Senior Sales National Trainer 
Bayer
Starting as a pharmacist, Dallas has always been focused on optimizing patient outcomes. She brings thirty years of experience creating and delivering game changing programs for pharma professionals to help them focus on optimizing patient outcomes while building sales – and having fun! She is a  Senior National Trainer at Bayer Inc in Canada.
Jenna Weed
 Jenna Weed 
Sr. Manager, Sales Training 
AMAG Pharmaceuticals
Michael Banks
 Michael Banks 
President 
The Doctors Channel
Larry Westfall
 Larry Westfall 
VP, Value-Based Care 
Pharmacist Partners
David Rhew
 David Rhew 
Chief Medical Officer 
Samsung
Dr. David Rhew is the Chief Medical Officer (CMO) and Head of Healthcare and Fitness for Samsung Electronics America.  David received his Bachelors of Science degrees in computer science and cellular molecular biology from the University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai Medical Center and infectious diseases at the University of California, Los Angeles.
Dr. Rhew has served as CMO and Vice-President for Global Healthcare at Samsung SDS; Senior Vice-President and CMO at Zynx Health Incorporated; clinician/researcher in the Division of Infectious Diseases at the VA Greater Los Angeles Healthcare System; and Associate Clinical Professor of Medicine at UCLA. Dr. Rhew has served on the National Quality Forum’s (NQF) Steering Committee for Pulmonary and Critical Care quality indicators and is currently on the NQF Consensus Standards and Approval Committee. He co-holds six U.S. technology patents that enable the authoring, mapping, and integration of clinical decision support into the electronic health record. 
Dr. Rhew’s interests include measurably improving the quality, safety, and efficiency of patient care and applying technology to engage patients and consumers in their health care. 

Bob Rossilli
 Bob Rossilli 
Vice President, Sales 
Bio Products Laboratory
Anita Burell
 Anita Burell 
President & CEO 
Anita Burrell Consulting LLC
Anita Burrell is a dynamic, passionate and infectiously enthusiastic consultant focused on improving patient outcomes through pharmaceutical innovation. She is also an adjunct assistant professor at Rutgers University and a regular speaker on health economics, market access and mHealth.
Anita has 23 years of experience in the pharmaceutical industry in a wide variety of roles.  She has been responsible for strategic commercial execution on the Sanofi diabetes portfolio, led Aubagio, the oral MS therapy through submission and approval in over 30 markets worldwide and been responsible for global pricing, reimbursement support and market access for launch products throughout her career.

Anita joined the pharmaceutical industry as a pioneer in the field of Health Economics for Burroughs Wellcome. After increasingly senior roles within the UK, she moved to New Jersey in 2001 where she has made her home apart from a sojourn for Sanofi to spend 4 years in Paris, France . 

Anita holds a BA (Hons) in Economics from the University of Stirling, an M.A. in Economics from Dalhousie University, Nova Scotia, Canada, and a Masters in Business Administration from Kingston University, Surrey UK. 

In her spare time she is a Director at Large for the Mid Atlantic chapter of the Healthcare Businesswomen’s Association, likes to read a wide variety of literature, ride horses and experience different cultures through travel.

John Crowley
 John Crowley 
Vice President 
Cardinal Health
John Colleran
 John Colleran 
Principal 
Todd Strategy Group
Andy Walter
 Andy Walter 
VP, Commercial Services; Retired Board & Strategic Advisor 
Procter & Gamble; Verix
Doron Aspitz
 Doron Aspitz 
CEO 
Verix
Doron Aspitz is a visionary and seasoned executive, with over 20 years of technical and business management experience in growing technology companies in dynamic markets. Doron specializes in building and expanding early-stage companies with a customer-centric approach.
Doron was previously co-founder, chairman, and CEO of Blue Pumpkin Software, a leading workforce management solutions company. Blue Pumpkin received numerous industry accolades for transforming the way companies manage employees and improve their customers’ experience. Call Center Magazine awarded Doron with their “Pioneer of the Year” award as a tribute to his industry contributions. Doron drove Blue Pumpkin to achieve strong profitability and growth during difficult times and led the company to a very successful acquisition by Witness Systems (NASDAQ: WITS) in 2005. Prior to founding Blue Pumpkin, Doron held global business and senior technical management positions at Tandem Corporation and IBM. Doron holds a Masters in MIS and a B.Sc. in Economics and Statistics, both from the Tel Aviv University.

Lance Scott
 Lance Scott 
CEO 
Zephyr Health
Don DeStefano
 Don DeStefano 
Vice President, Business Development 
LexisNexis Risk Solutions
Dan Henry
 Dan Henry 
Executive Director of Life Sciences Solutions 
Outcome Health
Paul Darling
 Paul Darling 
Principal 
ZS Associates
Paul Darling is a Principal with ZS Associates in the firm’s San Francisco office.  Paul assists life sciences companies in evaluating new markets, acquisitions, and licensing opportunities as well as developing the associated go-to-market strategies.  He has presented at several industry conferences on the topics of forecasting, asset valuation, and alliance structuring. 

Paul developed and leads ZS's Institute on U.S. Healthcare Evolution and Scenario Planning.  He is currently exploring opportunities for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform, including new business models, therapies, acquisitions, and partnerships, as well as reimagining the commercial model to support such portfolio changes.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in Statistical Thermodynamics from Washington University.

John Santaferraro
 John Santaferraro 
Chief Analytics Officer 
Educational Measures, LLC
John Santaferraro is the chief analytics officer at Educational Measures. With 20 years of experience as a big data analytics imagineer, he is responsible for driving the next-generation of meeting and event analytics. Previously, he was the interim CMO at Diyotta and vice president of marketing at ParAccel until it was purchased by Actian, where he stayed in that position to help guide the transition. He began his career in technology as the co-founder of a data warehouse software startup that eventually sold to Teradata. Along the way he has held executive big data marketing positions in top tech companies including Tandem, Compaq, and HP. When he’s not hiking, skiing, or snowshoeing in the Colorado Rockies, John loves to cook gourmet, collect fine wine, and brew craft beer.
Jason Bhan
 Jason Bhan 
MD, Co-Founder & Chief Medical Officer 
Prognos
Jason Bhan, MD, is a Family Physician and serves as the Chief Medical Officer at Medivo. He is regarded as a national expert in the applications of technology to healthcare and medicine, a topic on which he speaks regularly at institutions and conferences, such as Health 2.0, mHealth, New York’s eHealth Collaborative, and Health Datapalooza. He also has done extensive strategy consulting with pharmaceutical companies.

From 2007-2010, Dr. Bhan worked with Clinovations and managed several large hospital system EHR implementations, outcomes measurements and data analysis. Dr. Bhan obtained his Doctor of Medicine at the University of Miami School of Medicine and he is board certified in Family Medicine.

 Venkat Thiruvallur 
Senior Director, Global Strategic Marketing 
EMD Serono
Charleen Ring
 Charleen Ring 
Program Director 
PharmaForce
Charleen is an experienced content director, market researcher and published author with a passion for creative storytelling. She produces innovative b2b networking conferences that serve as platforms to help businesses and professionals create narratives that inspire and foster connectivity between industry thought leaders. Her portfolio currently focuses on events in the life sciences and travel, hospitality and leisure industries. She manages WBR’s Digital Travel Summit, PharmaForce, MedForce, and NGPX. When not developing awesome programs, you can find her working on her next novel, traveling with her husband, or Instagramming photos of her beloved French Bulldog, Marv. 

We're already at work booking an industry-leading roster of speakers for 2017 - keep an eye on this page for updates.

If you would be interested in being a part of Pharmaforce 2017, we would love to hear from you.

Click Here to view the list of speakers from our 2016 event.